Grants per year
Personal profile
Research Interests
Crohn's disease and Ulcerative Colitis
Certifications and Licenses
| Gastroenterology | |
| Internal Medicine |
Training Experience
| 1978 | Internship, University of Chicago |
| 1980 | Residency, University of Chicago |
| 1982 | Fellowship, University of Chicago |
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1977
Research interests keywords
- Inflammatory Bowel Disease
Fingerprint
Dive into the research topics where stephen B Hanauer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #IM047029: A Phase 4, Prospective, Open‐label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clinical Practice
PPD Investigator Services, LLC, Celgene International II Sàrl
9/25/23 → 9/25/26
Project: Research project
-
: Prot #78934804CRD2001: A Phase 2b Randomized, Double‐blind, Active‐ and Placebo‐controlled, Parallel‐ group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Partici
Parexel, Janssen Research & Development, LLC
6/12/23 → 8/24/28
Project: Research project
-
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
Bonner, L. B., Dulai, P. S., Hanauer, S. B., Hirano, I., Scholtens, D. M., Sumagin, R. & Yang, G.
National Institute of Diabetes and Digestive and Kidney Diseases
3/15/23 → 2/28/28
Project: Research project
-
Prot# Cx601-0303: A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem cells (eASC), for the treatment of complex
Bellaguarda, E. A. L. & Hanauer, S. B.
7/30/21 → 7/30/24
Project: Research project
-
A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis
D'Haens, G., Peyrin-Biroulet, L., Marks, D. J. B., Lisi, E., Liefaard, L., Beaton, A., Srinivasan, N., Bouma, G., Prasad, N., Cameron, R., Kayali, Z., Tarzi, R., Hanauer, S. & Sandborn, W. J., Aug 2023, In: Alimentary Pharmacology and Therapeutics. 58, 3, p. 283-296 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
COVID-19 and Inflammatory Bowel Disease
Summa, K. C. & Hanauer, S. B., Mar 2023, In: Gastroenterology Clinics of North America. 52, 1, p. 103-113 11 p.Research output: Contribution to journal › Review article › peer-review
-
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis
Hanauer, S., Wang, Y. & Shatila, M., Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 150-151 2 p.Research output: Contribution to journal › Editorial › peer-review
1 Scopus citations -
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease
Colombel, J. F., Sands, B. E., Gasink, C., Yeager, B., Adedokun, O. J., Izanec, J., Ma, T., Gao, L. L., Lee, S. D., Targan, S. R., Ghosh, S., Hanauer, S. B. & Sandborn, W. J., 2023, (Accepted/In press) In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Article › peer-review
Open Access -
Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change
Taft, T. H., Mcgarva, J., Omprakash, T. A., Tomasino, K., Pandit, A., Mutlu, E. A. & Hanauer, S. B., May 1 2023, In: Inflammatory bowel diseases. 29, 5, p. 675-683 9 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations